ACT And Roslin Cells Announce Collaboration For Storage And Distribution Of Embryonic Stem Cells Using ACT’s Blastomere Technology
June 22, 2011
Advanced Cell Technology, Inc. (“ACT”; OTCBB: ACTC), a leader in the field of regenerative medicine, announced that it has entered into a definitive collaborative agreement with Roslin Cells LTD (“Roslin Cells”) of Scotland. The two companies will work together to establish a bank of Good Manufacturing Practice (GMP)-grade human embryonic stem cell (hESC) lines using ACT’s patented, proprietary “single-cell blastomere” technique for deriving hESC lines without destroying embryos. (Medical News Today)
